EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
1-Year Return
51.18%
This Quarter Return
+7.26%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$2.14B
AUM Growth
+$234M
(+12%)
Cap. Flow
+$180M
Cap. Flow
% of AUM
8.41%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
153
New
13
Increased
61
Reduced
17
Closed
9
Top Buys
| 1 |
GTT
GTT Communications, Inc.
GTT
|
$22.6M |
| 2 |
Varonis Systems
VRNS
|
$18.8M |
| 3 |
Arista Networks
ANET
|
$16.9M |
| 4 |
Roper Technologies
ROP
|
$16.6M |
| 5 |
HubSpot
HUBS
|
$15.4M |
Top Sells
| 1 |
Trade Desk
TTD
|
$16.3M |
| 2 |
Twilio
TWLO
|
$9.47M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$6.46M |
| 4 |
AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
|
$6.27M |
| 5 |
Protagonist Therapeutics
PTGX
|
$5.72M |
Sector Composition
| 1 | Healthcare | 38.18% |
| 2 | Technology | 17.61% |
| 3 | Consumer Discretionary | 12.18% |
| 4 | Industrials | 9.62% |
| 5 | Utilities | 3.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DERM
101
DELISTED
Dermira, Inc.
DERM
| $2.67M | 0.13% |
334,000
+210,000
| +169% | +$1.68M |
|
102
Incyte
INCY
$16.8B
| $2.58M | 0.12% |
31,000
+4,000
| +15% | +$333K |
|
103
Acadia Pharmaceuticals
ACAD
$4.31B
| $2.55M | 0.12% |
113,600
-221,100
| -66% | -$4.97M |
|
|
DLPH
104
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $2.51M | 0.12% |
52,666
| – | – |
|
|
FRTX
105
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $2.47M | 0.12% |
5,397
| – | – |
|
106
Neurogene
NGNE
$277M
| $2.46M | 0.12% |
8,750
| – | – |
|
107
First Hawaiian
FHB
$3.24B
| $2.46M | 0.12% |
88,500
+15,400
| +21% | +$429K |
|
108
Aclaris Therapeutics
ACRS
$216M
| $2.45M | 0.11% |
140,000
| – | – |
|
109
Johnson Controls International
JCI
$69.9B
| $2.34M | 0.11% |
66,500
+14,000
| +27% | +$493K |
|
|
ABB
110
DELISTED
ABB Ltd.
ABB
| $2.26M | 0.11% |
95,000
+19,700
| +26% | +$468K |
|
|
RARX
111
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.06M | 0.1% |
+388,000
| New | +$2.06M |
|
112
Honda
HMC
$44.3B
| $2.05M | 0.1% |
59,000
+4,650
| +9% | +$161K |
|
|
SYRS
113
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.95M | 0.09% |
15,000
| – | – |
|
|
SEP
114
DELISTED
Spectra Engy Parters Lp
SEP
| $1.85M | 0.09% |
55,000
-7,500
| -12% | -$252K |
|
115
PTC Therapeutics
PTCT
$4.47B
| $1.85M | 0.09% |
68,200
| – | – |
|
116
ESSA Pharma
EPIX
$11M
| $1.83M | 0.09% |
481,971
+346,000
| +254% | +$1.31M |
|
117
TSMC
TSM
$1.21T
| $1.82M | 0.09% |
41,500
+3,000
| +8% | +$131K |
|
|
FPRX
118
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.8M | 0.08% |
105,000
-210,000
| -67% | -$3.61M |
|
|
TERP
119
DELISTED
TerraForm Power, Inc
TERP
| $1.73M | 0.08% |
161,000
+57,700
| +56% | +$619K |
|
|
BDN
120
Brandywine Realty Trust
BDN
$752M
| $1.64M | 0.08% |
103,500
+22,000
| +27% | +$349K |
|
121
Bunge Global
BG
$16.4B
| $1.6M | 0.08% |
21,700
+3,400
| +19% | +$251K |
|
|
TSRO
122
DELISTED
TESARO, Inc.
TSRO
| $1.49M | 0.07% |
26,000
| – | – |
|
123
Tandem Diabetes Care
TNDM
$832M
| $1.36M | 0.06% |
+275,000
| New | +$1.36M |
|
124
Eaton
ETN
$135B
| $1.36M | 0.06% |
17,000
+4,300
| +34% | +$343K |
|
125
Prothena Corp
PRTA
$439M
| $1.36M | 0.06% |
37,000
-83,000
| -69% | -$3.05M |
|